We designed experiments to determine the role of endothelium-derived contracting factor or factors in the response to endothelin-1 and endothelin-3 in the aorta of normotensive and hypertensive rats. Rings of thoracic aortas, with and without endothelium, from normotensive and spontaneously hypertensive rats were suspended in organ chambers for recording of isometric tension in the presence of nitro-L-arginine, an inhibitor of nitric oxide synthase. The removal of endothelium decreased the contractions evoked by both endothelins in the aorta of spontaneously hypertensive but not of normotensive rats. Indomethacin (inhibitor of cyclooxygenase), dazoxiben (inhibitor of thromboxane synthase), and SQ-29,548 (antagonist of thromboxane A 2 receptors) reduced, in aortic rings of spontaneously hypertensive rats, the contractions to endothelins in rings with but not in those without endothelium, whereas their effect was not endothelium-dependent in tissues of normotensive rats. BQ-123, a selective endothelin-A receptor antagonist, shifted the concentration-response curve to endothelin-1 to the right in a concentrationdependent manner and abolished the endothelium-dependent component of the contractions evoked by the peptide. The presence of the endothelium increased the basal and endothelin-stimulated release of thromboxane B 2 , the stable metabolite of thromboxane A 2 , in aortas of spontaneously hypertensive rats but not in those of normotensive rats. These data suggest that endothelium-derived thromboxane A 2 contributes to contractions evoked by endothelin-1 and endothelin-3 in the aorta of the spontaneously hypertensive rat but not in that of the normotensive rat. Both the receptors on the endothelial cells (mediating the release of thromboxane A 2 ) and those on vascular smooth muscle belong to the endothelin-A subtype. However, in the aorta of spontaneously hypertensive rat (SHR), the endothelium-dependent relaxations to acetylcholine are blunted by the concomitant release of a cyclooxygenase-dependent endothelium-derived contracting factor, which most likely is an endoperoxide. 4 ' 5 In the same preparation, with endothelium from both the SHR and normotensive Wistar-Kyoto (WKY) rat, the direct constrictor effect of endothelin-1 (ET-1) and endothelin-3 (ET-3) on the vascular smooth muscle is blunted by the release of endothelium-derived relaxing factor (most likely nitric oxide). 67 In addition, in aorta with endothelium from the hypertensive but not from the normotensive strain, contractions to ET-1 are reduced by the inhibitor of cyclooxygenase indomethacin, suggesting that the peptide causes the release of a